The American Journal of Gastroenterology 2025
13 papers
The 2025 edition of The American Journal of Gastroenterology features research centered on metabolic therapies, digital health integration, and clinical management strategies. A recurring theme involves the investigation of GLP-1 receptor agonists, specifically their impact on inflammatory bowel disease activity in patients with obesity and their effects on esophageal motility. Additionally, the application of artificial intelligence is prominent, with studies exploring its role in classifying ulcerative colitis severity and enhancing patient empowerment in liver cancer care.
Clinical trials and case reports further define the year's contributions. The SHEEL multicenter randomized controlled trial examined the safety of early oral refeeding in patients with chronic pancreatitis following extracorporeal shock wave lithotripsy. Other research addressed the natural history of upper gastrointestinal bleeding from tumors and rare clinical presentations, such as the secretory diarrhea variant of Ogilvie's syndrome. Prolific contributors to this year's volume include Gevork Salmastyan, John J. Kim, and Loren Laine. These works reflect a focus on integrating emerging pharmacological trends with technological advancements in diagnostic and therapeutic protocols.
Top Authors
| Author | Papers |
|---|---|
| Bjørn Leth Møller | 1 |
| Christian Igel | 1 |
| Jiang Bian | 1 |
| Tian Ye | 1 |